Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Cabral-Miranda

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
ASN Neuro|February 23, 2023
Age-Associated Upregulation of Glutamate Transporters and Glutamine Synthetase in Senescent Astrocytes In Vitro and in the Mouse and Human HippocampusIsadora Matias, Luan Pereira Diniz, Ana Paula Bergamo Araujo, et al.
Alzheimer'S Research & Therapy|February 14, 2026
Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohortPaulina Orellana, Fernando Henríquez, Felipe Cabral-Miranda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2023
The unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease by improving synaptic function and proteostasisClaudia Duran-Aniotz, Natalia Poblete, Catalina Rivera-Krstulovic, et al.
The EMBO Journal|December 14, 2021
Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisDanilo Bilches Medinas, Sajid Malik, Esra Yıldız-Bölükbaşı, et al.
The EMBO Journal|October 31, 2022
Unfolded protein response IRE1/XBP1 signaling is required for healthy mammalian brain agingFelipe Cabral-Miranda, Giovanni Tamburini, Gabriela Martinez, et al.
Nature Aging|February 13, 2026
Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin AmericaAriel Caviedes, Felipe Cabral-Miranda, Paulina Orellana, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
ASN Neuro|February 23, 2023
Age-Associated Upregulation of Glutamate Transporters and Glutamine Synthetase in Senescent Astrocytes In Vitro and in the Mouse and Human HippocampusIsadora Matias, Luan Pereira Diniz, Ana Paula Bergamo Araujo, et al.
Alzheimer'S Research & Therapy|February 14, 2026
Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohortPaulina Orellana, Fernando Henríquez, Felipe Cabral-Miranda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2023
The unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease by improving synaptic function and proteostasisClaudia Duran-Aniotz, Natalia Poblete, Catalina Rivera-Krstulovic, et al.
The EMBO Journal|December 14, 2021
Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisDanilo Bilches Medinas, Sajid Malik, Esra Yıldız-Bölükbaşı, et al.
The EMBO Journal|October 31, 2022
Unfolded protein response IRE1/XBP1 signaling is required for healthy mammalian brain agingFelipe Cabral-Miranda, Giovanni Tamburini, Gabriela Martinez, et al.
Nature Aging|February 13, 2026
Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin AmericaAriel Caviedes, Felipe Cabral-Miranda, Paulina Orellana, et al.
Pageof 2